Annual FCF
-$56.34 M
-$35.77 M-173.90%
December 31, 2023
Summary
- As of February 26, 2025, BRNS annual free cash flow is -$56.34 million, with the most recent change of -$35.77 million (-173.90%) on December 31, 2023.
- During the last 3 years, BRNS annual FCF has fallen by -$45.02 million (-397.64%).
- BRNS annual FCF is now -397.64% below its all-time high of -$11.32 million, reached on December 1, 2020.
Performance
BRNS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$18.31 M
-$6.11 M-50.12%
September 30, 2024
Summary
- As of February 26, 2025, BRNS quarterly free cash flow is -$18.31 million, with the most recent change of -$6.11 million (-50.12%) on September 30, 2024.
- Over the past year, BRNS quarterly FCF has stayed the same.
- BRNS quarterly FCF is now -293.21% below its all-time high of $9.48 million, reached on September 1, 2022.
Performance
BRNS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$62.09 M
-$7.08 M-12.88%
September 30, 2024
Summary
- As of February 26, 2025, BRNS TTM free cash flow is -$62.09 million, with the most recent change of -$7.08 million (-12.88%) on September 30, 2024.
- Over the past year, BRNS TTM FCF has stayed the same.
- BRNS TTM FCF is now -1329.66% below its all-time high of -$4.34 million, reached on March 1, 2020.
Performance
BRNS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BRNS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -173.9% | 0.0% | 0.0% |
| 3 y3 years | -397.6% | -53.5% | -201.9% |
| 5 y5 years | - | -23.5% | -112.9% |
BRNS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -173.9% | at low | -293.2% | +8.3% | -264.5% | +1.1% |
| 5 y | 5-year | -397.6% | at low | -293.2% | +8.3% | -1329.7% | +1.1% |
| alltime | all time | -397.6% | at low | -293.2% | +8.3% | -1329.7% | +1.1% |
Barinthus Biotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.31 M(+50.1%) | -$62.09 M(+12.9%) |
| Jun 2024 | - | -$12.20 M(+0.6%) | -$55.01 M(-12.4%) |
| Mar 2024 | - | -$12.13 M(-37.6%) | -$62.79 M(+11.4%) |
| Dec 2023 | -$56.34 M(+173.9%) | -$19.45 M(+73.2%) | -$56.34 M(+15.4%) |
| Sep 2023 | - | -$11.23 M(-43.8%) | -$48.82 M(+73.7%) |
| Jun 2023 | - | -$19.98 M(+251.7%) | -$28.11 M(+51.3%) |
| Mar 2023 | - | -$5.68 M(-52.4%) | -$18.58 M(-9.7%) |
| Dec 2022 | -$20.57 M | -$11.93 M(-225.9%) | -$20.57 M(+20.7%) |
| Sep 2022 | - | $9.48 M(-190.7%) | -$17.04 M(-40.6%) |
| Jun 2022 | - | -$10.45 M(+36.2%) | -$28.66 M(-13.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7.67 M(-8.6%) | -$33.04 M(-2.0%) |
| Dec 2021 | -$33.73 M(+197.9%) | - | - |
| Dec 2021 | - | -$8.40 M(+291.2%) | -$33.73 M(+10.9%) |
| Sep 2021 | - | -$2.15 M(-85.5%) | -$30.42 M(+4.3%) |
| Jun 2021 | - | -$14.83 M(+77.3%) | -$29.17 M(+90.2%) |
| Mar 2021 | - | -$8.36 M(+64.2%) | -$15.34 M(+35.5%) |
| Dec 2020 | -$11.32 M | -$5.09 M(+471.4%) | -$11.32 M(+81.7%) |
| Sep 2020 | - | -$891.00 K(-10.5%) | -$6.23 M(+16.7%) |
| Jun 2020 | - | -$996.00 K(-77.1%) | -$5.34 M(+22.9%) |
| Mar 2020 | - | -$4.34 M | -$4.34 M |
FAQ
- What is Barinthus Biotherapeutics annual free cash flow?
- What is the all time high annual FCF for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual FCF year-on-year change?
- What is Barinthus Biotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly FCF year-on-year change?
- What is Barinthus Biotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics TTM FCF year-on-year change?
What is Barinthus Biotherapeutics annual free cash flow?
The current annual FCF of BRNS is -$56.34 M
What is the all time high annual FCF for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual free cash flow is -$11.32 M
What is Barinthus Biotherapeutics annual FCF year-on-year change?
Over the past year, BRNS annual free cash flow has changed by -$35.77 M (-173.90%)
What is Barinthus Biotherapeutics quarterly free cash flow?
The current quarterly FCF of BRNS is -$18.31 M
What is the all time high quarterly FCF for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly free cash flow is $9.48 M
What is Barinthus Biotherapeutics quarterly FCF year-on-year change?
Over the past year, BRNS quarterly free cash flow has changed by $0.00 (0.00%)
What is Barinthus Biotherapeutics TTM free cash flow?
The current TTM FCF of BRNS is -$62.09 M
What is the all time high TTM FCF for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high TTM free cash flow is -$4.34 M
What is Barinthus Biotherapeutics TTM FCF year-on-year change?
Over the past year, BRNS TTM free cash flow has changed by $0.00 (0.00%)